Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

Go back to Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: ELOX) Delayed: 13.74 -1.44 (9.49%)
Previous Close $15.18    52 Week High $ 
Open $15.02    52 Week Low $ 
Day High $15.29    P/E N/A 
Day Low $13.21    EPS $ 
Volume 31,308